Results 301 to 310 of about 3,300,951 (351)
Some of the next articles are maybe not open access.
2016
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Updated studies on development of HIV therapeutic vaccine.
Current HIV Research, 2019BACKGROUND Among various types of pharmaceuticals, vaccines have a special place. However, in the case of HIV nearly after 40 years of its discovery an effective vaccine still is not available.
M. S. Larijani +2 more
semanticscholar +1 more source
Recombinant Therapeutic Protein Vaccines
Protein & Peptide Letters, 2013Recombinant technology has ushered in a new era for the pharmaceutical industry. Protein therapeutics, including plasma-derived products and antibodies obtained from the serum of infected patients, have been successfully adopted and utilized to treat various indications.
Satoshi, Ohtake, Tsutomu, Arakawa
openaire +2 more sources
Journal of Infection, 2002
In this review, we address recent advances in the understanding of the pathogenesis of human immunodeficiency type 1 virus infection, which have provided the rationale for present trials of therapeutic vaccines. We shall relate this work to lessons of the past few years both in the use of highly active antiretroviral therapy to attempt eradication of ...
S, Kinloch-de Loes, B, Autran
openaire +2 more sources
In this review, we address recent advances in the understanding of the pathogenesis of human immunodeficiency type 1 virus infection, which have provided the rationale for present trials of therapeutic vaccines. We shall relate this work to lessons of the past few years both in the use of highly active antiretroviral therapy to attempt eradication of ...
S, Kinloch-de Loes, B, Autran
openaire +2 more sources
In the wake of the novel Coronavirus, it has become imperative to develop vaccines that can alert our immune system to the virus, hence reducing the severity of disease if exposed to it. Different types of vaccines have been studied in this respect, such as nucleic acid vaccines (mRNA and DNA vaccines), vector-based vaccines, whole-virus vaccines ...
Walid Shaban, Abdella +4 more
openaire +2 more sources
Walid Shaban, Abdella +4 more
openaire +2 more sources
Therapeutic vaccines for leishmaniasis
Expert Opinion on Biological Therapy, 2014Numerous therapeutic strategies are used to treat leishmaniasis. The treatment of cutaneous leishmaniasis (CL) is solely depends on antimonate derivatives with safety issues and questionable efficacy and there is no fully effective modality to treat CL caused by Leishmania tropica and Leishmania braziliensis.There is no prophylactic vaccine available ...
openaire +2 more sources
Modelling Therapeutic Vaccines
2020Prophylactic vaccines have dramatically reduced the worldwide burden of many vaccine-preventable diseases. However, several diseases, including cancer, autoimmune diseases, Alzheimer’s, and some infectious diseases, continue to cause significant morbidity, mortality, and socioeconomic upheavals.
Elaheh Abdollahi +2 more
openaire +1 more source
Therapeutic HIV Peptide Vaccine
2015Therapeutic vaccines aim to control chronic HIV infection and eliminate the need for lifelong antiretroviral therapy (ART). Therapeutic HIV vaccine is being pursued as part of a functional cure for HIV/AIDS. We have outlined a basic protocol for inducing new T cell immunity during chronic HIV-1 infection directed to subdominant conserved HIV-1 epitopes
openaire +3 more sources
Therapeutic Clonotypic Vaccines
New England Journal of Medicine, 1992In this issue of the Journal, Kwak et al.1 give us a progress report concerning their work on the vaccination of patients with lymphoma against their own cancerous cells.
openaire +1 more source